These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 10713693

  • 1. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
    Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND.
    Oncogene; 2000 Feb 21; 19(8):1077-84. PubMed ID: 10713693
    [Abstract] [Full Text] [Related]

  • 2. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L.
    Dev Biol; 2001 Jan 01; 229(1):163-75. PubMed ID: 11133161
    [Abstract] [Full Text] [Related]

  • 3. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
    Manhès C, Kayser C, Bertheau P, Kelder B, Kopchick JJ, Kelly PA, Touraine P, Goffin V.
    J Endocrinol; 2006 Aug 01; 190(2):271-85. PubMed ID: 16899561
    [Abstract] [Full Text] [Related]

  • 4. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.
    Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493
    [Abstract] [Full Text] [Related]

  • 5. Possible role of Stat5a in rat mammary gland carcinogenesis.
    Shan L, Yu M, Clark BD, Snyderwine EG.
    Breast Cancer Res Treat; 2004 Dec 15; 88(3):263-72. PubMed ID: 15609129
    [Abstract] [Full Text] [Related]

  • 6. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1976 Oct 15; 36(10):3726-31. PubMed ID: 821605
    [Abstract] [Full Text] [Related]

  • 7. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW, Wagner KU, Hennighausen L.
    Oncogene; 2001 Oct 25; 20(48):7115-9. PubMed ID: 11704837
    [Abstract] [Full Text] [Related]

  • 8. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
    Tomblyn S, Langenheim JF, Jacquemart IC, Holle E, Chen WY.
    Int J Oncol; 2005 Nov 25; 27(5):1381-9. PubMed ID: 16211235
    [Abstract] [Full Text] [Related]

  • 9. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 25; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 10. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H.
    Mol Endocrinol; 2002 May 25; 16(5):1108-24. PubMed ID: 11981045
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone increases Stat5 and Stat1 expression in lactating goat mammary gland: a specific effect compared to milking frequency.
    Boutinaud M, Jammes H.
    Domest Anim Endocrinol; 2004 Nov 25; 27(4):363-78. PubMed ID: 15519040
    [Abstract] [Full Text] [Related]

  • 12. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E, Groner B, Barash I.
    Mol Cancer Res; 2002 Nov 25; 1(1):32-47. PubMed ID: 12496367
    [Abstract] [Full Text] [Related]

  • 13. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.
    Welte T, Garimorth K, Philipp S, Doppler W.
    Mol Endocrinol; 1994 Aug 25; 8(8):1091-102. PubMed ID: 7527899
    [Abstract] [Full Text] [Related]

  • 14. Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b.
    Liu X, Gallego MI, Smith GH, Robinson GW, Hennighausen L.
    Cell Growth Differ; 1998 Sep 25; 9(9):795-803. PubMed ID: 9751123
    [Abstract] [Full Text] [Related]

  • 15. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
    Liu X, Robinson GW, Hennighausen L.
    Mol Endocrinol; 1996 Dec 25; 10(12):1496-506. PubMed ID: 8961260
    [Abstract] [Full Text] [Related]

  • 16. Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.
    Flint DJ, Boutinaud M, Whitelaw CB, Allan GJ, Kolb AF.
    J Mol Endocrinol; 2006 Jun 25; 36(3):435-48. PubMed ID: 16720715
    [Abstract] [Full Text] [Related]

  • 17. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H.
    Mol Cell Biol; 2004 Jun 25; 24(12):5510-20. PubMed ID: 15169911
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional changes underlying the secretory activation phase of mammary gland development.
    Naylor MJ, Oakes SR, Gardiner-Garden M, Harris J, Blazek K, Ho TW, Li FC, Wynick D, Walker AM, Ormandy CJ.
    Mol Endocrinol; 2005 Jul 25; 19(7):1868-83. PubMed ID: 15705664
    [Abstract] [Full Text] [Related]

  • 19. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M, Graessmann A.
    Oncogene; 2001 Apr 26; 20(18):2325-32. PubMed ID: 11402328
    [Abstract] [Full Text] [Related]

  • 20. Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure.
    Gourdou I, Paly J, Hue-Beauvais C, Pessemesse L, Clark J, Djiane J.
    Biol Reprod; 2004 Mar 26; 70(3):718-28. PubMed ID: 14613905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.